The Deka SmartXide2 MLT (MonaLisa Touch) is the best-known and most widespread fractional CO2 laser system designed to treat vulvovaginal conditions. Combined with with V2LR (Vulvo Vaginal Laser Reshaping) configuration, Deka SmartXide2 MLT offers the latest breakthrough laser treatment for the MLT procedure and cosmetic/functional female genital surgery.
Vaginal mucosa and skin differ significantly in epithelium structure. The outer skin layer has plenty of keratin and little water, while mucosal epithelium is nonkeratinized, containing water and glycogen. Due to their different levels of hydration, the CO2 laser (highly absorbed by water) has different effects on skin and on mucosa. It follows that in order to stimulate these two tissues in depth, two different barriers have to be overcome. Therefore, a laser conceived for skin rejuvenation does not have the same efficacy on mucosa. To perform these innovative procedures, Deka designed a new radiofrequency CO2 laser featuring proprietary PSD (Pulse Shape Design) technology. This generates the only pulse specifically developed for treating genital mucosa: D-Pulse or DEKAPulse.
The D-Pulse consists of:
• an initial portion with constant high-peak power for rapid painless superficial removal of atrophic epithelial mucosa
• a second variable portion, with lower peak power and longer emission times, that allows the laser energy to penetrate into the mucosa and stimulate it properly in depth
System Features
• Effective: the sole procedure demonstrated by clinical, histological and ultrastructural studies published in the international peer-reviewed literature
• Simple: in-office non-surgical procedure, 5-minute treatments; the ergonomic scanner and probes make it easy to perform
• Safe: virtually side effect-free, minimally invasive, thousands of women successfully treated since 2009
• Painless: requiring no anesthesia inside the vagina with very short downtime
• Immediate: symptom relief after just one treatment, even greater improvement after treatments 2 and 3
• Non-hormonal therapy: suitable for patients who cannot, or prefer not to receive estrogen therapy
• Cost-efficient: cheaper than alternatives involving tablets or creams that need to be taken/applied every day for months and that only focus on symptoms rather than address the causes
